Skip to content Skip to footer
Close

Impressum

Merz Therapeutics GmbH
Eckenheimer Landstrasse 100
60318 Frankfurt am Main
Germany

Phone: +49-(0)69-15 03-0
Fax: +49-(0)69-15 03-830
Email: toxnet-group@merz.de

Management

Merz Therapeutics GmbH
Eckenheimer Landstrasse 100
60318 Frankfurt am Main
Germany

Geschäftsführung: Stefan König (CEO), Dr. Stefan-Alexander Albrecht, Michael Schwaninger

Handelsregister: Amtsgericht Frankfurt am Main, HRB 123488
Rechtsform: Gesellschaft mit beschränkter Haftung
USt.Id.-Nr. DE344390214

Aufsichtsbehörde im Sinne des Arzneimittelgesetzes

Regierungspräsidium Darmstadt
Luisenplatz 2
64283 Darmstadt
Germany

Inhalte

Merz Therapeutics GmbH
Eckenheimer Landstrasse 100
60318 Frankfurt am Main
Germany

Information zur Verbrauchendenschlichtung: Die Merz Therapeutics GmbH ist weder bereit noch verpflichtet, an Streitbeilegungsverfahren vor einer Schlichtungsstelle für Verbrauchende teilzunehmen.  Die EU-Kommission stellt eine Plattform zur Online-Streitbeilegung (OS-Plattform) verbraucherrechtlicher Streitigkeiten bereit, die aus Online-Kaufverträgen und Online-Dienstleistungsverträgen resultieren. Diese Plattform erreichen Sie im Internet unter: http://ec.europa.eu/consumers/odr/.

© 2024 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.